Free Trial

Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Quanterix logo with Medical background
Remove Ads

Quanterix (NASDAQ:QTRX - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.03), Zacks reports. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. The business had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.93 million. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Trading Up 1.9 %

NASDAQ:QTRX traded up $0.14 during midday trading on Friday, hitting $7.38. 242,902 shares of the company traded hands, compared to its average volume of 505,176. The firm's fifty day moving average is $8.23 and its 200-day moving average is $10.88. Quanterix has a 12-month low of $6.30 and a 12-month high of $26.18. The firm has a market capitalization of $284.31 million, a P/E ratio of -6.99 and a beta of 1.34.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lowered their target price on Quanterix from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday.

Read Our Latest Research Report on Quanterix

About Quanterix

(Get Free Report)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

Featured Stories

Earnings History for Quanterix (NASDAQ:QTRX)

Should You Invest $1,000 in Quanterix Right Now?

Before you consider Quanterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.

While Quanterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Stock Market on Sale – Buy Now Before the Next Big Surge
Google’s $32B Move: 3 Cybersecurity Stocks to Watch
$3,000 Gold & Climbing! Is This Your Last Chance to Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads